Rethinking Clinical Trials

MARCH 20, 2025

Dr. Sara Singer, principal investigator for iPATH Researchers from iPATH, an NIH Collaboratory Trial, described key considerations for integrating artificial intelligence tools into analyses of qualitative data. The report was posted this month on the AcademyHealth Blog. The iPATH trial, led by principal investigator Sara Singer at Stanford University, will test the implementation of a practice transformation strategy for type 2 diabetes in federally qualified health centers in California, Massa

Clinical Trials 147

Clinical Trials Clinical Trials Trials Research 147

Pharmaceutical Technology

MARCH 20, 2025

OBT has entered a multi-year partnership with Roche to discover antibody-based therapeutics for cancer treatment.

Antibody 288

Antibody 288

Bio Pharma Dive

MARCH 20, 2025

To Novartis, fresh late-stage data support the idea that its intrathecal drug, which has the same active ingredient as Zolgensma, could be approved for a broad range of spinal muscular atrophy patients.

Gene Therapy 201

Gene Therapy Gene Drugs 201

Pharmaceutical Technology

MARCH 20, 2025

Pfizer has divested its residual shareholding in Haleon, representing 7.3% of the company's share capital, for a total of $3.3bn.

255

255

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Clinical Trials

Drug Patent Watch

MARCH 20, 2025

Unlock the Full Potential of Your Pharmaceutical Product: The Power of a CDMO As a pharmaceutical professional, you're constantly looking for ways to bring innovative products to market faster and more efficiently. One key strategy that can help you achieve this goal is partnering with a Contract Development and Manufacturing Organization (CDMO). But what exactly is a CDMO, and how can it benefit your business?

Production 90

Production Manufacturing Marketing Development 90

AuroBlog - Aurous Healthcare Clinical Trials blog

MARCH 20, 2025

After a long, stressful day at work, or when pressed for time, the temptation to have a quick, satisfying snack like crisps or a chocolate bar can be strong.

Development 195

Development Research Clinical Trials Clinical Trials 195

Pharmaceutical Technology

MARCH 20, 2025

A key trend seen in 2024 and recent years is the simplification of basket sizes, as countries look to streamline and simplify.

162

162

Drug Patent Watch

MARCH 20, 2025

Navigating the Complex World of Biosimilar Regulatory Agency Interactions As a biosimilar developer, you know that getting your product to market can be a long and arduous process. One of the most critical components of this journey is interacting with regulatory agencies. But how can you ensure that these interactions are effective and set your product up for success?

Production 52

Production Development Marketing 52

Pharmaceutical Technology

MARCH 20, 2025

Biotech and biopharma companies have battled with a drought of private investment in recent years but could now face government funding cuts.

Trials 147

Trials 147

Intouch Solutions

MARCH 20, 2025

Every March, South by Southwest takes over Austin, TX, with a conference-festival hybrid showcasing the latest in tech-driven creativity. EVERSANA INTOUCH has been there every year for more than a decade, engaging with leaders and distilling our experiences into actionable insights for our clients. At SXSW 2025, we heard loud and clear: Pharma marketers are facing the biggest challenge of our careers.

Marketing 59

Marketing 59

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Medicine

Pharmaceutical Technology

MARCH 20, 2025

Sanofis move for Dren Bios clinical asset boosts its immunology-focused strategy of becoming a leader in the field.

Antibody 147

Antibody 147

Drug Discovery World podcast

MARCH 20, 2025

This is the latest episode of the free DDW narrated podcast, titled Critical tools that support drug discovery and development, which covers two articles written for DDW Volume 24 Issue 3, Summer 2023.They are called: You think you need an ELN but are you asking the right questions? and Big data: Charting a new path to drug discovery and development .

Development 52

Development Life Science Drugs Big Data 52

Pharmaceutical Technology

MARCH 20, 2025

Servier and Black Diamond Therapeutics have signed a licencing agreement for targeted therapy, BDTX-4933, aimed at addressing solid tumours.

147

147

Crucial Data Soutions

MARCH 20, 2025

What Is BYOD in Clinical Trials? Bring Your Own Device (BYOD) is changing the way clinical trials collect and manage. The post Bring Your Own Device (BYOD) Clinical Trials: How They Transform Decentralized Data Capture appeared first on Crucial Data Solutions.

Clinical Trials 52

Clinical Trials Clinical Trials Trials 52

Advertisement

Clinical Supply

Pharmaceutical Technology

MARCH 20, 2025

Investigators said that the OLE study showed Roches gantenerumab dropped the risk of developing Alzheimer's symptoms by 50%.

Drugs 147

Drugs Development 147

CTTI (Clinical Trials Transformation Initiative)

MARCH 20, 2025

In September 2023, CTTI launched the Measuring Trials Transformation (MTT) Project to track progress toward CTTIs Transforming Trials 2030 (TT2030) vision. Introduced in 2021, this vision outlines how clinical trials should evolve by 2030 to become more efficient and inclusive, focusing on five key pillars: patient-centeredness, integration with health processes, trials designed with a quality approach, data-driven approaches, and improving population health.

Clinical Trials 45

Clinical Trials Clinical Trials Trials Development 45

Pharmaceutical Technology

MARCH 20, 2025

Among the 13 CAR-T therapeutics that have received regulatory approval are Gileads Yescarta and Immuneel Therapeutics Qartemi.

147

147

pharmaphorum

MARCH 20, 2025

A study has suggested early targeting of amyloid in the brains of people with inherited Alzheimer's can delay symptoms, but not all are convinced.

90

90

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

Pharmaceutical Commerce

MARCH 20, 2025

Jonathan James, CEO, Hope Charities, discusses the critical importance of maintaining access to life-saving medications for patients with rare diseases to lead productive lives.

Production 88

Production 88

Pharma Times

MARCH 20, 2025

The update is aimed at strengthening local and national surveillance

Regulation 72

Regulation 72

pharmaphorum

MARCH 20, 2025

Brain-computer interface specialist Synchron has previewed an AI model that it believes will form the basis of a new generation of devices.

71

71

Pharma Marketing Network

MARCH 20, 2025

Introduction The landscape of healthcare marketing is evolving faster than ever, with new digital trends, regulatory updates, and consumer behaviors reshaping the industry on a weekly basis. For pharma marketing executives and their teams, staying ahead requires agility, data-driven decision-making, and a proactive approach. But how can marketing teams effectively navigate these rapid changes without losing efficiency?

Marketing 52

Marketing Compliance Branding Regulation 52

Advertisement

Clinical Supply

pharmaphorum

MARCH 20, 2025

UK pharma leaders have renewed calls for a rethink by the government on levies imposed on medicine sales, saying investment is already being hit.

Sales 66

Sales Medicine 66

Pharmaceutical Commerce

MARCH 20, 2025

The session provides an overview of the uninsured population, and also tackles challenges faced by patients when it comes to accessing PAPs.

52

52

pharmaphorum

MARCH 20, 2025

Less than 18 months after its IPO, CAR-T developer CARGO has abandoned its development efforts and slashed around 90% of its staff

Development 59

Development 59

Pharmaceutical Commerce

MARCH 20, 2025

The latest news for pharma industry insiders.

52

52

Advertisement

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

Clinical Trials

pharmaphorum

MARCH 20, 2025

Sanofi buys a drug from Dren Bio to claim a stake in the emerging field of deep B-cell depletion for autoimmune diseases.

Drugs 59

Drugs 59

XTalks

MARCH 20, 2025

The pharmaceutical and biotechnology industries offer some of the most rewarding career opportunities in the US. Find out the top pharma and biotech companies to work for in the US in 2025. Whether youre a scientist developing life-saving treatments, a regulatory expert ensuring drug safety or a business professional driving strategic growth, the right workplace makes a difference.

Sales 59

Sales Production Drugs Development 59

pharmaphorum

MARCH 20, 2025

Stay informed about IRA updates and understand the impact of chaos in Washington with insights from expert Alice Valder Curran. Learn how to navigate the latest developments and make sense of it all.

Development 52

Development 52

Bio Pharma Dive

MARCH 20, 2025

Amvuttra’s clearance in a rare form of cardiomyopathy could help Alnylam turn a regular profit — if it can wrest control of a competitive and fast-changing market.

FDA Approval 285

FDA Approval Drugs Marketing 285

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Clinical Research